Showing results (4921-4930 of 5,051) with videos related to

Sort By:
Pageof 506
Headache|June 10, 2020
Calcitonin Gene-Related Peptide Receptor Antagonists (Gepants) for the Acute Treatment of Nausea in Episodic Migraine: A Systematic Review and Meta-AnalysisTommy Lik Hang Chan, Robert P Cowan, Yohannes W Woldeamanuel
Headache|June 11, 2020
COVID-19 and Headache: A Primer for TraineesSarah M Bobker, Matthew S Robbins
Headache|June 4, 2020
Chronic Migraine With Apparent Loss of Response to Onabotulinum Toxin Type A Due to Local Nitroglycerin Treatment for an Anal Fissure: A Case ReportSara Pérez-Pereda, Vicente González-Quintanilla, Jorge Madera, et al.
Headache|May 22, 2021
Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraineEvan Popoff, Karissa Johnston, Robert Croop, et al.
Headache|July 2, 2025
Greater occipital nerve block for chronic headache management in children and adolescents: A longitudinal observational study and systematic reviewMaria Morozova, Stewart MacLeod, Raymond Carragher, et al.
Headache|June 30, 2025
A 52-week open-label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraineDavid Kudrow, Robert S Croop, Alexandra Thiry, et al.
Headache|December 15, 2025
OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trialAndrew M Blumenfeld, Larry Charleston, Deena Kuruvilla, et al.
Headache|December 3, 2025
A retrospective audit of the real-world safety and effectiveness profile of eptinezumab for treatment-resistant chronic migraine in AustraliaLakshini Gunasekera, Shuli Cheng, Emma Foster, et al.
Headache|June 19, 2025
Regulation of Na+, K+-ATPase by cardiotonic steroids: Participation in the sodium theory for migraineRoger Gregory Biringer
Headache|December 27, 2024
Effectiveness of switching strategies in CGRP monoclonal antibody therapy for migraine: A retrospective cohort studyAlex Jaimes, Andrea Gómez, Olga Pajares, et al.
Pageof 506